TTM
-143.6%
YoY change
−33.85pp
Trough year (2019)
-853.7%
Peak year (2021)
68.8%
Latest annual
-145.2%
Net Profit Margin history chart for Moderna (MRNA) from 2016 to 2025
Latest: -145.2%
Net Profit Margin change chart for Moderna (MRNA) from 2016 to 2025
Latest: −33.85pp
Net Profit Margin history table for Moderna (MRNA) from 2016 to 2025
| 2025 | -145.2% | -33.85pp | ||
| 2024 | -111.3% | -42.48pp | ||
| 2023 | -68.8% | -113.14pp | ||
| 2022 | 44.3% | -24.50pp | ||
| 2021 | 68.8% | +161.79pp | ||
| 2020 | -93.0% | +760.74pp | ||
| 2019 | -853.7% | -568.88pp | ||
| 2018 | -284.8% | -160.51pp | ||
| 2017 | -124.3% | +75.13pp | ||
| 2016 | -199.5% | — |
- 2025-145.2%-33.85pp
- 2024-111.3%-42.48pp
- 2023-68.8%-113.14pp
- 202244.3%-24.50pp
- 202168.8%+161.79pp
- 2020-93.0%+760.74pp
- 2019-853.7%-568.88pp
- 2018-284.8%-160.51pp
- 2017-124.3%+75.13pp
- 2016-199.5%—
Net Profit Margin values are taken from Moderna's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Profit Margin at Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported net margin is -143.6%. Net profit margin is net income divided by revenue — the bottom-line share of each sales dollar that remains after all costs, including operating expenses, interest, and taxes. It is the most comprehensive profitability ratio, though it can swing on one-off items, so read it alongside the multi-year trend below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual net margin for Moderna (MRNA) came in at -145.16% – contracted 33.8 percentage points year-over-year.
The highest annual net margin of 68.80% was reported in 2021. The lowest in the available history was -853.73% in 2019.
Moderna Net Profit Margin by Year
Moderna Net Profit Margin 2025: -145.2%
In 2025, Moderna reported net margin of -145.16%, contracted 33.8 percentage points from 2024.
Moderna Net Profit Margin 2024: -111.3%
Moderna net margin in 2024 was -111.32%, contracted 42.5 percentage points from 2023.
Moderna Net Profit Margin 2023: -68.8%
2023's net margin for Moderna came in at -68.84%, contracted 113.1 percentage points from 2022.
Moderna Net Profit Margin 2022: 44.3%
Moderna posted net margin of 44.30% in 2022, contracted 24.5 percentage points from 2021.
Moderna Net Profit Margin 2021: 68.8%
Moderna net margin in 2021 was 68.80%.
See more financial history for Moderna (MRNA).
Sector peers by Net Profit Margin
Healthcare peers of Moderna (MRNA), ranked by their latest net margin
| 37.2% | |
| 35.0% | |
| 21.4% | |
| 20.9% | |
| 17.2% | |
| 13.6% | |
| 5.8% | |
| 2.7% |
- 37.2%
- 35.0%
- 20.9%
- 17.2%
- 13.6%
- 5.8%
Frequently asked questions
Moderna (MRNA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation